HUMAN BioPlazma Kft. – a subsidiary of Kedrion Biopharma – informs that, as of February 1st, 2021, all its KEDPLASMA plasma collection centers in Hungary will be operating under a new owner, Haema Plasma Kft. Through HUMAN BioPlazma Kft., Kedrion Biopharma will continue to operate in the country with the distribution of plasma-derived medicinal products.
In accordance with international, national and local authority guidelines, Kedrion has acted immediately in dealing with the epidemiological emergency linked to the spread of the new Coronavirus (SARS-CoV-2), and has taken all necessary measures to safeguard the health and safety of its employees and guarantee continuation of business activities. Paolo Marcucci, Chairman & CEO has
You are now leaving www.kedrion.hu. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.